Skip to main content
Equibles

PALISADE CAPITAL MANAGEMENT, LP

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1009006 FORT LEE, NJ
Back to TMO Full portfolio

Position in TMO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,794,718
-$41,217 QoQ
Shares Held
11,558
-2.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#797
of 2,620 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

PALISADE CAPITAL MANAGEMENT, LP holds $66,109,829 across 6 Diagnostics & Research names. TMO ranks #4 (8.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DHR
Danaher Corp /De/
 130,142 $24,789,448
2 MTD
Mettler Toledo International Inc/
 10,620 $13,567,156
3 RDNT
RadNet, Inc.
 199,431 $12,298,909
4 TMO
Thermo Fisher Scientific Inc.
This page 		11,558 $5,794,718
5 CSTL
Castle Biosciences Inc
 231,931 $5,531,554
6 ICLR
Icon PLC
 23,764 $4,128,044

All Filings in TMO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,794,718 11,558
2026-03-31 $5,835,935 11,873
2025-12-31 $6,186,787 10,677
2025-09-30 $4,788,117 9,872
2025-06-30 $4,002,701 9,872
2025-03-31 $4,912,307 9,872
2024-12-31 $5,083,687 9,772
2024-09-30 $5,982,809 9,672
2024-06-30 $5,297,740 9,580
2024-03-31 $4,893,788 8,420
2023-12-31 $5,554,717 10,465
2023-09-30 $5,285,427 10,442
2023-06-30 $5,604,638 10,742
2023-03-31 $6,191,366 10,742
2022-12-31 $5,976,087 10,852
2022-09-30 $5,458,378 10,762
2022-06-30 $5,846,779 10,762
2022-03-31 $6,356,575 10,762
2021-12-31 $7,084,087 10,617
2021-09-30 $6,065,810 10,617
2021-06-30 $4,615,900 9,150
2021-03-31 $3,055,464 6,695
2020-12-31 $2,396,438 5,145
2020-09-30 $2,262,790 5,125
2020-06-30 $1,856,992 5,125
2020-03-31 $1,453,450 5,125